VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Birchtree Investments Ltd. (“Birchtree” or the “Company”) (CSE: BRCH), an investment company with the long-term goal of divesting its investment assets at a profit, today announces the execution of a non-binding term sheet dated December 30, 2025 (the “Term Sheet”) to acquire a 50% equity interest of Digital Motion Corporation (“Digital Motion”), ‎a private Delaware-based corporation focused on redefining digital markets globally with Web3 products and proprietary innovation. Digital Motion brings together advanced financial technologies across capital formation, credit infrastructure, and real-world assets (RWA’s), to provide both traditional and progressive investors with diversified exposure to innovative Web3-driven financial products. Digital Motion’s mission is...

QUEBEC CITY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce that at its special meeting of shareholders (the “Meeting”) held today, shareholders (“Robex Shareholders”) voted overwhelmingly in favour of the special resolution (the “Arrangement Resolution”) approving the previously announced merger with Predictive Discovery Limited (“Predictive”) pursuant to which Predictive, through its direct wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Robex (“Robex Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Québec). Voting Results The Arrangement Resolution was approved by 94.54% of votes cast by Robex Shareholders represented in person or by proxy at the Meeting, satisfying the required approval threshold...

Israeli defense technology pioneer, supplier to IAI, Elbit, and Rafael, now a wholly owned Nukkleus subsidiary NEW YORK and TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK), (the “Company”), a strategic acquirer and developer of high-growth aerospace and defense businesses, today announced the closing of its acquisition of Tiltan Software Engineering Ltd. (“Tiltan”), a 30-year leader in defense AI simulation, synthetic data generation, and GPS-denied navigation systems. Tiltan is now a wholly owned subsidiary of the Company. Tiltan’s technology is embedded in some of the world’s most advanced defense programs. Tiltan’s simulation platforms train pilots and operators for Israel Aerospace Industries, its synthetic data accelerates machine learning development for Elbit Systems, and its GPS-denied...

Colorado-based Company to Reaffirm Gold and Precious Metals Resources MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), today announced the engagement of Colorado-based Hard Rock Consulting, LLC (“HRC”) to reaffirm the gold and precious metals reserves of Montana Tunnels Mining, Inc. and the Montana Tunnels Mine, a wholly owned subsidiary and asset of Montana Goldfields, Inc. (“MGLD” or “Montana Goldfields”). As previously announced, Captivision has executed a letter of intent (LOI) to acquire Montana Tunnels Mining, Inc. Upon completion of the acquisition, the Company intends to reposition as a diversified gold mining and related services business and will be renamed Montana Gold Inc. (Nasdaq: MGI). HRC specializes in geology and exploration, resource estimation and data...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Dec. 30, 2025 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) is pleased to announce it has closed the acquisition of Red Leaf Resources Inc. (“Red Leaf”) through the exchange of Red Leaf common shares for Class “A” Common voting shares (“Questerre Common Shares”). Michael Binnion, President and Chief Executive Officer of Questerre, commented, “The closing of the Red Leaf acquisition is another step forward in our strategy to commercialize oil shale as a globally competitive resource. Red Leaf hold rights to over several hundred million barrels of oil share resource in Utah. In Jordan, we are negotiating an extension...

Creates a scaled, high performing regional bank with $23 billion in assets strategically located in attractive New Jersey, Long Island and New York markets Meaningfully enhances profitability metrics with estimated EPS accretion of 16%, ROATCE of 13% and ROAA of 1.00% by 2027 $225 million equity raise, priced at-the-market, is fully committed at a fixed price after extensive investor due diligence by Warburg Pincus1RED BANK, N.J. and UNIONDALE, N.Y., Dec. 29, 2025 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ: “OCFC”), (“OceanFirst”), the holding company for OceanFirst Bank N.A., and Flushing Financial Corp. (NASDAQ: “FFIC”) (“Flushing”), the holding company for Flushing Bank, today announced entry into a definitive merger agreement pursuant to which the companies will combine in an all-stock merger transaction. Upon...

BERLIN, Dec. 30, 2025 (GLOBE NEWSWIRE) — Sportstech Brands Holding GmbH (“Sportstech”) refers to discussions with Interactive Strength, Inc. (Nasdaq: TRNR), which have been ongoing since the end of 2024 regarding a potential acquisition of Sportstech. As part of these discussions, the parties have so far been unable to agree on key economic and strategic terms. Against this background, the negotiations have been suspended effective November 27, 2025, and at present, there is no mutually agreed basis to advance the process toward a binding agreement. Currently, no further discussions are taking place. The planned market entry of Sportstech into the U.S. market was an integral part of the strategic considerations in connection with the proposed acquisition. Due to the termination of the discussions, this objective cannot be achieved...

Proposed Business Combination with Nasdaq-listed EKSO to Form an Accelerated Focused GPU Platform Purpose Built for Next-Generation AI Workloads DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) — Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, and EKSO Bionics Holdings, Inc. (Nasdaq: EKSO) (“EKSO”) announced today that Applied Digital and EKSO entered into a non-binding term sheet for a proposed business combination of Applied Digital’s cloud computing business, Applied Digital Cloud, with EKSO, which, once closed, will go forward as ChronoScale Corporation, an accelerated compute platform purpose-built to support artificial intelligence (“AI”) workloads (the “Proposed...

Royalty Pharma will now own 100% of the 8% to 16% Evrysdi royalty following multiple transactions with PTC since 2020 NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired the final portion of PTC Therapeutics’ remaining royalty on Roche’s Evrysdi for $240 million upfront and up to $60 million in sales-based milestones. Evrysdi, marketed by Roche, is an orally administered survival motor neuron-2 (SMN2) splicing modifier for the treatment of spinal muscular atrophy. Evrysdi was approved by the FDA in 2020 and has treated over 21,000 patients worldwide. In 2024, Evrysdi generated sales of approximately CHF 1.6 billion ($1.9 billion), representing 18% year-over-year growth at constant exchange rates, and is projected to reach CHF 2.3 billion ($2.9 billion) of sales by 2030...